• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS25
Device Problem Leak/Splash (1354)
Patient Problem Aortic Insufficiency (1715)
Event Date 10/01/2019
Event Type  Injury  
Event Description
On (b)(6) 2019 a patient was status post endocarditis, needing his aortic valve replaced.After dr.(b)(6) made incision (aortotomy) he discovered the patient might have evolving endocarditis and sent off the valve leaflets to pathology for confirmation one way or the other.It was determined by dr.(b)(6) and dr (b)(6) after sizing correctly to implant a large perceval valve into this patient.Because of the endocarditis dr (b)(6) was concerned about the annulus not looking normal more especially on the right coronary cusp area.The valve was deployed in the usual manner per the ifu's and both dr.(b)(6) and dr (b)(6) were pleased with the implant.The checks were completed the valve was balloon dilated followed by another round of checks the guiding sutures were removed and the aortotomy was closed.As the patient was being weaned from bypass a pvl was noted on the right side of the valve.Because of where the pvl was located and the area of said leak not having any real annular plane to speak of it was decided both by dr.(b)(6) and dr.(b)(6) to replace the valve with a sewn in valve.The re-clamping of the aorta extending the procedure by an additional 79 minutes, while the original time was 73 minutes for a total time of 196 minutes of pump time.
 
Manufacturer Narrative
Several attempts have been made to fu for further information and no additional details have been provided at this time.Because no further information is available and the device has not been returned no further investigations can be performed.Based on the information provided the suspected root cause of the event is procedural complications due to the patient anatomy associated with previous endocarditis and a lack of annular plane leading to a paravalvular leak.However, at this time because there is no further information available and the device could not be returned the exact root cause of the event could not be established.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
MDR Report Key9258326
MDR Text Key176128441
Report Number1718850-2019-01153
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000436
UDI-Public(01)00896208000436(240)ICV1210(17)220420
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup
Report Date 03/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/30/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/20/2022
Device Model NumberPVS25
Device Catalogue NumberICV1210
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date10/01/2019
Device Age6 MO
Event Location Hospital
Date Manufacturer Received10/01/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age33 YR
-
-